×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| SMS Lifesciences India Ltd | 800.52 | 51.58 | 790.43 | 17.06 | 352.0 | 20.4 |
| ZENOTECH LABORATORIES LTD. | NA | NA | NA | NA | 337 | 81.0 |
| Hemant Surgical Industries Lim | NA | NA | NA | NA | 328 | 41.0 |
SMS Lifesciences India Ltd, with Security Code 540679, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 65.6 | 74.6 | 67.8 | 71.2 | 86.4 | 86.6 | 78.5 | 82.9 | 85.4 | 79.0 |
| Expenses | 63.0 | 69.4 | 58.4 | 62.2 | 75.6 | 72.8 | 66.7 | 69.8 | 79.7 | 68.2 |
| Operating Profit | 2.5 | 5.1 | 9.5 | 9.0 | 10.8 | 13.8 | 11.8 | 13.1 | 5.7 | 10.8 |
| OPM % | 3.85% | 6.87% | 13.96% | 12.67% | 12.52% | 15.9% | 15.03% | 15.77% | 6.66% | 13.71% |
| Other Income | 4.6 | 0.6 | 0.3 | 0.6 | 2.3 | 0.4 | 1.3 | 0.1 | 2.2 | 1.0 |
| Interest | 1.4 | 1.8 | 2.5 | 2.0 | 2.6 | 2.2 | 1.9 | 2.0 | 1.8 | 1.7 |
| Depreciation | 2.1 | 2.5 | 2.6 | 2.5 | 2.6 | 2.5 | 2.6 | 2.6 | 2.6 | 2.6 |
| Profit before tax | 1.3 | 1.4 | 4.8 | 5.1 | 7.9 | 9.5 | 8.6 | 8.6 | 3.4 | 7.5 |
| Tax % | -32% | -48.5% | -34.7% | -34.6% | -25% | -32.3% | -29.8% | -27.7% | -18% | 31% |
| Net Profit | 2.5 | 0.7 | 3.1 | 3.3 | 5.9 | 6.5 | 6.0 | 6.2 | 2.7 | 5.2 |
| EPS in Rs | 8.17 | 2.32 | 10.31 | 10.96 | 19.63 | 21.37 | 19.87 | 20.6 | 0 | 17.06 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 88.3 | 63.7 | 74.7 | 69.3 | 72.1 | 90.0 | 92.5 | 78.5 | 84.6 | 89.1 |
| Expenses | 78.9 | 61.4 | 72.1 | 61.4 | 62.8 | 78.6 | 76.3 | 69.9 | 71.8 | 81.7 |
| Operating Profit | 9.4 | 2.3 | 2.5 | 7.9 | 9.3 | 11.4 | 16.3 | 8.6 | 12.8 | 7.4 |
| OPM % | 10.61% | 3.59% | 3.39% | 11.35% | 12.9% | 12.62% | 17.6% | 10.92% | 15.08% | 8.35% |
| Other Income | 0.5 | 4.8 | 0.6 | 0.3 | 0.6 | 2.4 | 0.4 | 2.0 | 0.1 | 2.3 |
| Interest | 1.7 | 1.8 | 2.2 | 2.8 | 2.3 | 2.8 | 2.4 | 2.1 | 2.1 | 2.0 |
| Depreciation | 2.6 | 2.9 | 3.7 | 3.7 | 3.7 | 3.8 | 3.7 | 3.8 | 3.8 | 3.8 |
| Profit before tax | 5.6 | 0.0 | -2.7 | 1.7 | 3.8 | 7.1 | 10.6 | 4.7 | 6.9 | 4.0 |
| Tax % | -31.3% | -10.7% | 40.4% | -126.6% | 8.2% | -8.8% | 33.3% | 29.8% | 29.8% | -10.2% |
| Net Profit | 3.8 | 2.1 | -3.8 | -0.4 | 4.1 | 6.5 | 7.1 | 3.3 | 4.9 | 3.5 |
| EPS in Rs | 13.18 | 5.66 | -5.94 | -2.2 | 14.24 | 19.53 | 23.15 | 15.46 | 18.08 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -3% |
| 3 Years: | 5% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -7% |
| 3 Years: | -4% |
| TTM: | 183% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 43% |
| 3 Years: | 30% |
| 1 Year: | 102% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -4% |
| 3 Years: | 5% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -19% |
| 3 Years: | -22% |
| TTM: | 660% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 43% |
| 3 Years: | 30% |
| 1 Year: | 102% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|